Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II-IV”

3,908 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,908 results

Testing effectiveness (Phase 2)Ended earlyNCT01533948
What this trial is testing

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT04541355
What this trial is testing

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Who this might be right for
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more
Hyunseok Kang, MD
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00968435
What this trial is testing

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT02568449
What this trial is testing

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Who this might be right for
Recurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT04245085
What this trial is testing

ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Who this might be right for
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
ETOP IBCSG Partners Foundation 95
Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Not applicableWithdrawnNCT01729832
What this trial is testing

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituRecurrent Breast Cancer+7 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004238
What this trial is testing

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00490711
What this trial is testing

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Eli Lilly and Company 7
Testing effectiveness (Phase 2)WithdrawnNCT00951444
What this trial is testing

Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)UnknownNCT00033722
What this trial is testing

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Tularik
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Testing effectiveness (Phase 2)Ended earlyNCT00323063
What this trial is testing

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 49
Large-scale testing (Phase 3)UnknownNCT00268411
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 80
Testing effectiveness (Phase 2)UnknownNCT00025064
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Cancer and Leukaemia Group 260
Testing effectiveness (Phase 2)Study completedNCT00511992
What this trial is testing

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Who this might be right for
Advanced Ovarian CarcinomaPrimary Peritoneal CarcinomaOvarian Carcinosarcoma
University of Oklahoma 20
Load More Results
16